On Tuesday 11 March, the European Commission adopted a proposal for a Regulation on critical medicinal products aimed at boosting Europe’s production capacity, in particular by diversifying supply chains and reducing the EU’s dependencies.
These measures should provide Europe with a more stable supply of critical medicinal products. They should also help to improve access and availability of other medicines of common interest (to treat rare diseases), where there are disparities between...